Liquidia (LQDA) Competitors

Liquidia (NASDAQ:LQDA) and MacroGenics (NASDAQ:MGNX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Which has more volatility and risk, LQDA or MGNX?

Liquidia has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, MacroGenics has a beta of 2.09, suggesting that its stock price is 109% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in LQDA or MGNX?

64.5% of Liquidia shares are held by institutional investors. Comparatively, 96.9% of MacroGenics shares are held by institutional investors. 31.6% of Liquidia shares are held by insiders. Comparatively, 10.0% of MacroGenics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has higher valuation & earnings, LQDA or MGNX?

MacroGenics has higher revenue and earnings than Liquidia. MacroGenics is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liquidia	$17.49M	60.03	-$78.50M	-$1.20	-11.51
MacroGenics	$58.75M	17.11	-$9.06M	-$0.16	-100.44

Does the media favor LQDA or MGNX?

In the previous week, Liquidia had 10 more articles in the media than MacroGenics. MarketBeat recorded 11 mentions for Liquidia and 1 mentions for MacroGenics. Liquidia's average media sentiment score of 0.33 beat MacroGenics' score of 0.00 indicating that Liquidia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Liquidia	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MacroGenics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend LQDA or MGNX?

Liquidia currently has a consensus price target of $21.00, suggesting a potential upside of 52.06%. MacroGenics has a consensus price target of $17.00, suggesting a potential upside of 5.79%. Given Liquidia's higher probable upside, equities analysts plainly believe Liquidia is more favorable than MacroGenics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Liquidia	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
MacroGenics	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

Does the MarketBeat Community favor LQDA or MGNX?

MacroGenics received 234 more outperform votes than Liquidia when rated by MarketBeat users. However, 66.30% of users gave Liquidia an outperform vote while only 63.28% of users gave MacroGenics an outperform vote.

Company	Underperform	Outperform
Liquidia	Outperform Votes 183 66.30%	Underperform Votes 93 33.70%
MacroGenics	Outperform Votes 417 63.28%	Underperform Votes 242 36.72%

Is LQDA or MGNX more profitable?

MacroGenics has a net margin of -15.42% compared to Liquidia's net margin of -448.89%. MacroGenics' return on equity of -88.49% beat Liquidia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Liquidia	-448.89%	-132.16%	-65.35%
MacroGenics	-15.42%	-88.49%	-43.12%

Summary

MacroGenics beats Liquidia on 11 of the 18 factors compared between the two stocks.